Jennifer Lachey
Director Técnico/Científico/I+D en KEROS THERAPEUTICS, INC. .
Cargos activos de Jennifer Lachey
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
KEROS THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 01/06/2019 | - |
Corporate Officer/Principal | 01/07/2016 | 01/06/2019 |
Historial de carrera de Jennifer Lachey
Antiguos cargos conocidos de Jennifer Lachey.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
SERES THERAPEUTICS, INC. | Director/Miembro de la Junta | 01/03/2015 | 01/07/2016 |
EMBER THERAPEUTICS, INC. | Corporate Officer/Principal | 01/07/2012 | 01/01/2015 |
ACCELERON PHARMA INC. | Corporate Officer/Principal | 01/01/2008 | 01/07/2012 |
Formación de Jennifer Lachey.
Indiana University | Undergraduate Degree |
University of Cincinnati (Ohio) | Doctorate Degree |
Estadísticas
Internacional
Estados Unidos | 7 |
Operativa
Corporate Officer/Principal | 3 |
Chief Tech/Sci/R&D Officer | 1 |
Director/Board Member | 1 |
Sectorial
Health Technology | 5 |
Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 3 |
---|---|
KEROS THERAPEUTICS, INC. | Health Technology |
SERES THERAPEUTICS, INC. | Health Technology |
EMBER THERAPEUTICS, INC. | Health Technology |
Empresas privadas | 1 |
---|---|
Acceleron Pharma, Inc.
Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis in June 2003 and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Jennifer Lachey
- Experiencia